Recent Development in Carbohydrate Based Anti-cancer Vaccines.
about
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer VaccinesBiosynthesis of rare hexoses using microorganisms and related enzymesSialyl-tn in cancer: (how) did we miss the target?Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.Tumor-Associated Glycans and Immune SurveillanceSynthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine developmentSignificant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.Chemoenzymatic synthesis of mono- and di-fluorinated Thomsen-Friedenreich (T) antigens and their sialylated derivatives.Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinicIntegrating ReSET with glycosyl iodide glycosylation in step-economy syntheses of tumor-associated carbohydrate antigens and immunogenic glycolipidsGlycan microarrays: new angles and new strategies.Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.Recent Developments in Synthetic Carbohydrate-Based Diagnostics, Vaccines, and Therapeutics.Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation.Metabolic engineering pathways for rare sugars biosynthesis, physiological functionalities, and applications-a review.6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.Sequential one-pot multienzyme (OPME) synthesis of lacto-N-neotetraose and its sialyl and fucosyl derivatives.Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine.Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model.Stereocontrolled 1,2-cis glycosylation as the driving force of progress in synthetic carbohydrate chemistry.Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.Quantifying the Efficiency of N-Phenyl-D-mannosamine to Metabolically Engineer Sialic Acid on Cancer Cell Surface.Ultrasonic Modified Sweet Potato Pectin Induces Apoptosis like Cell Death in Colon Cancer (HT-29) Cell Line.Synthesis of an S-Linked α(2→8) GD3 Antigen and Evaluation of the Immunogenicity of Its Glycoconjugate.Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment.2-Nitroglycals: Versatile Building Blocks for the Synthesis of 2-Aminoglycosides
P2860
Q26740513-9785DC20-9163-42D5-A592-99EACABDC479Q26826944-03B07F08-0B27-453B-96CA-B04B419FC72CQ33649572-AF391054-E336-410E-8F4F-1AD93BCD7562Q34478719-73818A06-08A2-4084-A337-D71FF2DC1600Q35705462-87E27BB0-DB2E-4417-BB3C-EAE2F62171ACQ35890610-D1E9D7C1-79A9-448B-8D5D-AFBB324E772BQ35920353-9F83FFFC-2EF4-4843-97EE-F0DED303B0ACQ36186712-13B05012-B2BB-44C5-9A08-8F59B292C750Q36331649-F7359BDE-F501-4C3A-B315-A0B8D291451CQ36497647-732242E6-DDF9-4105-A04D-D8A71134847EQ36501284-AE97E535-1459-4339-835B-4F829CA9957EQ36740938-EF557950-AECF-46CE-A7CE-169DE99BDFAFQ37076109-3A1BB21B-AC12-4A5F-B517-8A3A79306181Q37303845-B74D261D-F529-4AE6-9A28-8F89C57197F5Q37701761-57AFA382-C99D-4840-B6C8-2CF7E8AC9166Q38203886-203CC7A9-F6EE-4D3A-B886-44B8A6B5E6B2Q38298211-E3A9FF09-F9BB-4168-B9A3-26609ED5AE88Q38533442-BE00C830-86B3-4B65-BA5D-26A2FD591A2BQ38833511-F7B80390-B738-428E-BA79-7BF9ECC26F2CQ39405167-DAD165DB-DA2D-4120-9AA3-368D069A8F7FQ40541300-DD5C2F65-3E87-4E44-AF57-4F85AEFF4CAFQ41107254-9883623B-1E96-41DD-93FC-FB6F9BA20233Q41194257-739714DE-8B44-4192-8D94-991E4F4FC3F4Q41932626-A06AC166-6845-475B-9A97-47A0D8D18A86Q42495215-6F6C6D31-1389-47D8-8E38-B483E8796406Q42534609-0CFF3765-8435-4993-9918-0C30242D5113Q42549851-372D075D-1565-4F6F-B654-4652AE82ECAAQ46959023-BB61B1F3-0096-4947-B3E6-9CFE9FD5C245Q51098501-D538C16A-4AB1-4D3A-8AF8-6458E937B6E7Q55322543-0E18BBEE-440A-42D8-9C3E-E67034EC6BA8Q59071423-95209E07-2890-4F68-902C-204DA666DD5A
P2860
Recent Development in Carbohydrate Based Anti-cancer Vaccines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Recent Development in Carbohydrate Based Anti-cancer Vaccines.
@ast
Recent Development in Carbohydrate Based Anti-cancer Vaccines.
@en
type
label
Recent Development in Carbohydrate Based Anti-cancer Vaccines.
@ast
Recent Development in Carbohydrate Based Anti-cancer Vaccines.
@en
prefLabel
Recent Development in Carbohydrate Based Anti-cancer Vaccines.
@ast
Recent Development in Carbohydrate Based Anti-cancer Vaccines.
@en
P2860
P1476
Recent Development in Carbohydrate Based Anti-cancer Vaccines
@en
P2093
Xuefei Huang
Zhaojun Yin
P2860
P304
P356
10.1080/07328303.2012.659364
P577
2012-02-29T00:00:00Z